- Home
- GMGI vs ELDN Comparison
GMGI vs ELDN Comparison
Compare GMGI & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMGI | ELDN |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.8M | 123.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GMGI | ELDN |
|---|---|---|
| Price | $0.66 | $2.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $8.50 |
| AVG Volume (30 Days) | 214.9K | ★ 844.7K |
| Earning Date | 10-30-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $179,142,103.00 | N/A |
| Revenue This Year | $25.59 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 37.24 | N/A |
| 52 Week Low | $0.58 | $1.35 |
| 52 Week High | $2.50 | $4.97 |
Technical Indicators
Market Signals| Indicator | GMGI | ELDN |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 63.48 |
| Support Level | $0.60 | $1.70 |
| Resistance Level | $0.74 | $2.27 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 30.42 | 77.70 |
Price Performance
Historical ComparisonAbout GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.